Vuento M, Salonen E
Z Naturforsch C Biosci. 1981 Sep-Oct;36(9-10):863-8.
Purified human plasma fibronectin has been shown to agglutinate protease-treated red cells [Vuento, Hoppe-Seyler's Z. Physiol. Chem. 360, 1327-1333, (1979)]. The present report shows that the activity is inhibited by low concentrations of lectins and by macromolecular serum factors. Chemical modification of carboxyl groups of fibronectin strongly inhibited the activity, but modification of amino groups of guanidinium groups had little effect on the activity. The results suggest that fibronectin receptors on erythrocyte surface are carbohydrate-containing molecules. Humoral macromolecular factors may control the interaction of fibronectin with cell surfaces. Chemical modification studies indicate that the parts of the fibronectin molecule responsible for the hemagglutinin activity are different from those mediating the binding of fibronectin to collagen.
纯化的人血浆纤连蛋白已被证明能凝集经蛋白酶处理的红细胞[武恩托,《霍佩-赛勒生理化学杂志》360,1327 - 1333,(1979年)]。本报告表明,该活性受到低浓度凝集素和大分子血清因子的抑制。对纤连蛋白羧基进行化学修饰会强烈抑制该活性,但对氨基或胍基进行修饰对活性影响不大。结果表明,红细胞表面的纤连蛋白受体是含碳水化合物的分子。体液中的大分子因子可能控制纤连蛋白与细胞表面的相互作用。化学修饰研究表明,纤连蛋白分子中负责血凝素活性的部分与介导纤连蛋白与胶原蛋白结合的部分不同。